[
  {
    "ts": null,
    "headline": "Should You Continue to Retain Abbott Stock in Your Portfolio Now?",
    "summary": "ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.",
    "url": "https://finnhub.io/api/news?id=caec77ec22690084341e505387c600e34c94964080b126a57233e52b2c610ee2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750771980,
      "headline": "Should You Continue to Retain Abbott Stock in Your Portfolio Now?",
      "id": 135506411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.",
      "url": "https://finnhub.io/api/news?id=caec77ec22690084341e505387c600e34c94964080b126a57233e52b2c610ee2"
    }
  },
  {
    "ts": null,
    "headline": "Is This the Right Time to Hold EYE Stock in Your Portfolio?",
    "summary": "National Vision gains from America's Best momentum and strategic revamp, but solvency issues and rising costs weigh on profitability.",
    "url": "https://finnhub.io/api/news?id=b4b1945ecc4ebf260e46b45ada2022a6546873b442ec7219977845c171ade861",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750768500,
      "headline": "Is This the Right Time to Hold EYE Stock in Your Portfolio?",
      "id": 135506755,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "National Vision gains from America's Best momentum and strategic revamp, but solvency issues and rising costs weigh on profitability.",
      "url": "https://finnhub.io/api/news?id=b4b1945ecc4ebf260e46b45ada2022a6546873b442ec7219977845c171ade861"
    }
  }
]